Denver, CO (PRWEB) September 17, 2013
The Invisible Brain Injury Project (http://www.invisibleheadinjury.com), a partnership between the Tug McGraw Foundation and CereScan Corp. of Denver, CO, and others has recently surpassed the $100k mark in initial funding. This project is specifically geared to seek new and more efficient identification of and treatment for invisible wounds such as Mild-to-Moderate Traumatic Brain Injury (mTBI).
The Invisible Brain Injury Project is aimed at addressing mTBI sustained by current and former military members and is an endeavor sponsored in part by CereScan, a clinical facility dedicated to state of the art functional brain imaging for the identification of a wide array of brain based disorders.
John Kelley, Chairman and CEO of CereScan comments, “We are delighted to see the donations to this project continue to increase. When combining the power and capabilities of both The Tug McGraw Foundation and CereScan, the Invisible Brain Injury Project stands as a beacon of hope for the thousands of brain injured service members who are seeking assistance.” The continued growth of donations to this project speaks to an increasing national awareness of the problems confronted by our returning warfighters who have sustained an mTBI and the demonstrated track record of supporting innovative research in the neurosciences field.
With a focus on accurate and thorough identification of these injuries, all candidates will go through initial mTBI screening by CereScan. Investigators will qualify each candidate by measuring the existence of chronic mTBI. Once candidates have been qualified, they will undergo an innovative protocol of treatments geared at successfully addressing the specific areas of their brain that have shown significant neurological dysfunction. The qualified participants involved with the Invisible Brain Injury Project will take part in a three phased approach to address the identification, measurement, and treatment of their mTBIs.
After completion of the treatment regimen, all participants will undergo additional post-treatment functional brain imaging sessions provided by CereScan at predetermined intervals in order to measure changes that occurred as a result of the therapies.
This collaborative effort will be used to conduct a sophisticated medical validation project over a four-month period involving military service members afflicted with mTBI. Initial case studies have produced significant results including the reduction of mTBI symptoms, use of fewer medications, improved brain functionality and enhanced quality of life.
CereScan’s proprietary process includes the latest generation high resolution gamma cameras, highest quality radio-pharmaceuticals from GE Healthcare and Cardinal Health, the industry's leading brain image reconstruction software, specially trained physicians and a patent pending, research-based, functional brain data warehouse.
"mTBI is considered the signature injury of the wars in Iraq and Afghanistan and while its pathology is unclear, it's effects are devastatingly apparent. It is the mission of the Tug McGraw Foundation to enhance the understanding of brain related trauma and the factors that influence recovery. This study has the potential to create truly meaningful improvements in the health and well-being of active military personnel, veterans and their families," stated Jennifer Brusstar, President and CEO of Tug McGraw Foundation.
For further information on the Tug McGraw Foundation or to contribute to the Invisible Brain Injury Project, please call 707-933-6445 or visit http://www.invisibleheadinjury.com.
About the Tug McGraw Foundation
TMF was established by Tug McGraw in 2003 to raise funds to enhance the quality of life of children and adults with brain tumors and their families by stimulating and facilitating research that addresses the physical, social, emotional, cognitive, and spiritual impact of the disease. Recognizing that other areas of brain research—such as traumatic brain injury and Post traumatic Stress Disorder—inform the science surrounding brain cancer, TMF has widened its scope to include a broader spectrum of the neuroscience to support advances in medical care and quality of life for our nation’s battle-wounded, ill and injured service members. http://www.tugmcgraw.org
As a Denver based neuro-diagnostics company, CereScan combines state-of-the-art SPECT brain imaging technology with a patient centered model of care to provide the highest level of neuro-diagnostics available. Using high definition functional brain imaging, industry leading image reconstruction software, and an extensive library of clinical data, the CereScan medical team provides physicians, researchers, and patients with unmatched objective diagnostic information. CereScan helps patients and their physicians, counselors and families to better understand the biological bases of their conditions and disorders. For more information, please call (866) 722-4806 or visit http://www.CereScan.com